CHRS vs IONS · rev $26.6M vs rev $514.0M
Coherus BioSciences Inc (CHRS) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
Coherus BioSciences Inc (CHRS) is a biotechnology company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported CHRS revenue for 2026-06-30 was $26.6M. Net income was -$59.0M. CHRS currently screens at market cap $223.7M.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
CHRS currently screens at market cap $223.7M. IONS currently screens at market cap $12.28B.
Not investment advice. Open the CHRS and IONS stock pages for the full models.
Not investment advice.